MindWalk Holdings (HYFT) Other Non-Current Assets (2020 - 2026)
MindWalk Holdings (HYFT) reported Other Non-Current Assets of $90791.8 for Q1 2026, up 43.21% year-over-year from $63398.4 in Q1 2025, and down 1.6% quarter-over-quarter from $92272.5 in Q4 2025.
MindWalk Holdings (HYFT) Other Non-Current Assets (2020 - 2026) Analysis & Trends
MindWalk Holdings (HYFT) has 7 years of Other Non-Current Assets data on file, last reported at $90791.8 in Q1 2026.
- Other Non-Current Assets for Q1 2026 came in at $90791.8, up 43.21% year-over-year; the trailing twelve-month figure through Jan 2026 was $90791.8 (up 43.21% YoY), and the FY2025 annual result was $90453.8, up 42.61% from the prior year.
- Other Non-Current Assets declined to $90791.8 in Q1 2026 per HYFT's latest filing, from $92272.5 in the prior quarter.
- Over five years, Other Non-Current Assets peaked at $92428.7 in Q3 2025 and troughed at $62876.3 in Q1 2024.
- A 5-year average of $70066.2 and a median of $63709.1 in 2024 frame the typical range for Other Non-Current Assets.
- The sharpest annual moves came in 2022 and 2025: Other Non-Current Assets retreated 3.28% in 2022, then surged 45.47% in 2025.
- A 5-year view of Other Non-Current Assets shows it stood at $64749.0 in 2022, then fell by 0.91% to $64162.0 in 2023, then retreated by 0.71% to $63709.1 in 2024, then jumped by 44.83% to $92272.5 in 2025, then fell by 1.6% to $90791.8 in 2026.
- Business Quant data shows HYFT's Other Non-Current Assets at $90791.8 in Q1 2026, $92272.5 in Q4 2025, and $92428.7 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Other Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 723,416.35 Bn | 723,416.32 Bn | - | - |
| 2 | Belite Bio | 57,340.00 Bn | 57,340.00 Bn | - | 289.41 Mn |
| 3 | Quantum Biopharma | 19,125.08 Bn | 19,125.08 Bn | - | - |
| 4 | Legend Biotech | 3,262.00 Bn | 3,261.71 Bn | 242.10 Mn | 12.40 Mn |
| 5 | Akari Therapeutics | 1,789.67 Bn | 1,789.67 Bn | - | 60,000.00 |
| 6 | Evaxion A | 1,480.39 Bn | 1,480.37 Bn | - | - |
| 7 | Psyence Biomedical | 241.78 Bn | 241.78 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 113.54 Bn | 106.29 Bn | 2.59 Bn | 1.26 Bn |
| 9 | Abivax | 94.26 Bn | 94.26 Bn | - | - |
| 10 | MindWalk Holdings | 166.20 Mn | 156.06 Mn | 1.78 | 90,791.78 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jan 31, 2026 | 90,791.78 |
| Oct 31, 2025 | 92,272.51 |
| Jul 31, 2025 | 92,428.74 |
| Apr 30, 2025 | 88,543.81 |
| Jan 31, 2025 | 63,398.42 |
| Oct 31, 2024 | 63,709.12 |
| Jul 31, 2024 | 63,537.14 |
| Apr 30, 2024 | 63,426.74 |
| Jan 31, 2024 | 62,876.33 |
| Oct 31, 2023 | 64,161.97 |
| Jul 31, 2023 | 62,933.12 |
| Apr 30, 2023 | 63,558.23 |
| Jan 31, 2023 | 63,018.53 |
| Oct 31, 2022 | 64,749.01 |
| Jul 31, 2022 | 62,979.70 |
| Apr 30, 2022 | 64,743.52 |
| Jan 31, 2022 | 63,996.61 |
| Oct 31, 2021 | 62,839.58 |
| Jul 31, 2021 | 65,118.64 |
| Apr 30, 2021 | 62,749.50 |